Evidence map›Paper›PMID 33376671›Full record

ArticleLeukemia research reports2021

Successful treatment with

Asako Takeuchi, Toshinori Kondo, Taizo Tasaka, Seiko Yamada, Tadashi Hirose, Hirofumi Fukuda, Risa Shimizu, Yoshiko Matsuhashi, Eisei Kondo, Hideho Wada

Erratum issuedOpen access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia research reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Unveiling CrypticInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Asako TakeuchiDepartment of Hematology, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama Prefecture 701-0192, Japan.
Toshinori KondoDepartment of Hematology, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama Prefecture 701-0192, Japan.
Taizo TasakaDepartment of Transfusion Medicine and Cell Therapy, Saitama Medical Center, Saitama Medical School, Kawagoe, Japan.
Seiko YamadaDepartment of Hematology, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama Prefecture 701-0192, Japan.
Tadashi HiroseDepartment of Hematology, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama Prefecture 701-0192, Japan.
Hirofumi FukudaDepartment of Hematology, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama Prefecture 701-0192, Japan.
Risa ShimizuDepartment of Hematology, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama Prefecture 701-0192, Japan.
Yoshiko MatsuhashiDepartment of Hematology, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama Prefecture 701-0192, Japan.
Eisei KondoDepartment of Hematology, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama Prefecture 701-0192, Japan.
Hideho WadaDepartment of Hematology, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama Prefecture 701-0192, Japan.
Okayama Prefecture · JPKawasaki Medical School · JPSaitama Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute myeloid leukemia (AML) with

Indexed as

Acute myeloid leukemiaBCR-ABL1Philadelphia chromosomeTyrosine kinase inhibitor

Identifiers

PMID33376671
PMCPMC7758353
OpenAlexW3112641790

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.